SCHEMBL6408425

SCHEMBL6408425

O=C(CCl)CC(=O)Nc1ccc(Cl)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 5/20 0.57
NPC1 O15118 4/20 0.57
RAB9A P51151 3/20 0.57
ALDH1A1 P00352 5/20 0.54
POLB P06746 1/20 0.54
MEN1 O00255 4/20 0.54
GAA P10253 1/20 0.53
MAPT P10636 1/20 0.53
HPGD P15428 1/20 0.53
ALOX15 P16050 1/20 0.53
TSHR P16473 1/20 0.53
HSD17B10 Q99714 1/20 0.53
SMN1; SMN2 Q16637 3/20 0.51
HTT P42858 2/20 0.51
LMNA P02545 1/20 0.51
MITF O75030 2/20 0.50
XBP1 P17861 1/20 0.50
NPSR1 Q6W5P4 1/20 0.50
NOD2 Q9HC29 1/20 0.50
P2RX7 Q99572 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10617946 0.92 NPC1 (0.57) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL16922181 0.86 NPC1 (0.66) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL1503954 0.86 NPC1 (0.66) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL6408760 0.83 POLB (0.71) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL11739018 0.83 GAA (0.58) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL6407780 0.83 KMT2A (0.56) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL6414213 0.83 KMT2A (0.71) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL5364516 0.82 HTT (0.59) KMT2ANPC1RAB9AALDH1A1POLB
SCHEMBL11741540 0.80 CYP3A4 (0.65) KMT2ANPC1RAB9AALDH1A1MEN1
SCHEMBL1504229 0.80 ALDH1A1 (0.68) KMT2ANPC1RAB9AALDH1A1POLB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6921770-B2 2-Phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2005-07-26 US disclosed
EP-1311160-A4 2-PHENYLIMINOTHIAZOLINES, THEIR PREPARATION METHOD AND ANTI-RICE BLAST AGENT CONTAINING THE SAME KOREA INST SCI & TECH (KR) 2004-04-21 EP disclosed
US-20030203950-A1 2-Phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2003-10-30 US disclosed
EP-1311160-A1 2-PHENYLIMINOTHIAZOLINES, THEIR PREPARATION METHOD AND ANTI-RICE BLAST AGENT CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2003-05-21 EP disclosed
WO-2002013611-A1 2-PHENYLIMINOTHIAZOLINES, THEIR PREPARATION METHOD AND ANTI-RICE BLAST AGENT CONTAINING THE SAME KOREA INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) 2002-02-21 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030203950-A1 2-Phenyliminothiazolines, their preparation method and anti-rice blast agent containing the same TYR, SYPL1, SSBP1 KMT2A 2739/4885NPC1 4560/4885RAB9A 500/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.